- Home
- VNDA vs BIOX Comparison
VNDA vs BIOX Comparison
Compare VNDA & BIOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- BIOX
- Stock Information
- Founded
- VNDA 2002
- BIOX 2001
- Country
- VNDA United States
- BIOX Argentina
- Employees
- VNDA N/A
- BIOX N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- BIOX Agricultural Chemicals
- Sector
- VNDA Health Care
- BIOX Industrials
- Exchange
- VNDA Nasdaq
- BIOX Nasdaq
- Market Cap
- VNDA 237.9M
- BIOX 275.1M
- IPO Year
- VNDA 2006
- BIOX N/A
- Fundamental
- Price
- VNDA $4.33
- BIOX $4.14
- Analyst Decision
- VNDA Strong Buy
- BIOX Strong Buy
- Analyst Count
- VNDA 2
- BIOX 4
- Target Price
- VNDA $16.50
- BIOX $9.88
- AVG Volume (30 Days)
- VNDA 754.6K
- BIOX 188.3K
- Earning Date
- VNDA 05-07-2025
- BIOX 05-12-2025
- Dividend Yield
- VNDA N/A
- BIOX N/A
- EPS Growth
- VNDA N/A
- BIOX N/A
- EPS
- VNDA N/A
- BIOX 0.02
- Revenue
- VNDA $198,772,000.00
- BIOX $407,732,105.00
- Revenue This Year
- VNDA $14.36
- BIOX N/A
- Revenue Next Year
- VNDA $44.53
- BIOX $7.55
- P/E Ratio
- VNDA N/A
- BIOX $175.33
- Revenue Growth
- VNDA 3.18
- BIOX N/A
- 52 Week Low
- VNDA $3.85
- BIOX $3.51
- 52 Week High
- VNDA $6.75
- BIOX $13.18
- Technical
- Relative Strength Index (RSI)
- VNDA 43.42
- BIOX 44.30
- Support Level
- VNDA $4.27
- BIOX $4.10
- Resistance Level
- VNDA $4.46
- BIOX $4.71
- Average True Range (ATR)
- VNDA 0.22
- BIOX 0.38
- MACD
- VNDA 0.01
- BIOX 0.03
- Stochastic Oscillator
- VNDA 54.55
- BIOX 46.49
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About BIOX Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.